Schmitt F, Myara I, Benoit M O, Guillemain R, Amrein C, Dreyfus G, Paris M, Moatti N
Laboratoire de Biochimie, Hôpital Broussais, Paris, France.
Ann Biol Clin (Paris). 1989;47(5):237-41.
In patients with heart transplant, the combined determination of serum beta 2-microglobulin and urinary neopterin, as rejection marker, prevented the interference by renal function and cyclosporin therapy. Unfortunately, the simultaneous measurement of these two parameters cannot distinguish between a rejection episode and the early stage of viral infection.
在心脏移植患者中，联合测定血清β2-微球蛋白和尿新蝶呤作为排斥反应标志物，可避免肾功能和环孢素治疗的干扰。不幸的是，同时测量这两个参数无法区分排斥反应发作和病毒感染早期阶段。
